Offer - Urjas Oil for just ₹ 1 X
Zealata is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Chronic Myelogenous Leukemia. Other than this, Zealata has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Zealata. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Zealata as well, which are listed below. Normally, these side effects of Zealata are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Zealata has a Severe effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Zealata's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Zealata contraindications section.
Besides this, Zealata may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Zealata is not safe while driving, and is is not addictive in nature.
Zealata is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Zealata safe for pregnant women?
Zealata shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Zealata safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Zealata. Immediately discontinue Zealata if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Zealata on the Kidneys?
There may be some adverse effects on kidney after taking Zealata. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Zealata on the Liver?
Zealata has very mild side effects on the liver.
What is the effect of Zealata on the Heart?
The heart can be affected by Zealata. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Zealata should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zealata unless your doctor advises you to do so -
Is this Zealata habit forming or addictive?
Forming a habit of Zealata has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Zealata as you may feel sleepy.
Is it safe?
Zealata is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Zealata is not used to treat mental disorders.
Interaction between Food and Zealata
Taking Zealata with food is safe.
Interaction between Alcohol and Zealata
Information about the interaction of Zealata and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869